QSAR and 3D QSAR in drug design. Part 1: Methodology

Drug Discovery Today

Volumn 2, Issue 11, 1997, Pages 457-467

  Kubinyi, Hugo ^a  

^a BASF SE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG ACTIVITY; DRUG DESIGN; METHODOLOGY; PARTITION COEFFICIENT; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW;

EID: 0030771347     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(97)01079-9     Document Type: Review

References (47)

1. Ramsden, C.A., ed. (1990) Quantitative Drug Design (Comprehensive Medicinal Chemistry) (Vol. 4), Fergamon Press
2. Kubinyi, H. (1993) QSAR: Hansch Analysis and Related Approaches, VCH
3. Hansch, C. and Leo, A. (1995) Exploring QSAR. Fundamentals and Applications in Chemistry and Biology, American Chemical Society
4. Hansch, C., Leo, A. and Hoekman, D. (1995) Exploring QSAR. Hydrophobic, Electronic, and Steric Constants, American Chemical Society
5. van de Waterbeemd, H., ed. (1995) Chemometric Methods in Molecular Design, VCH
6. van de Waterbeemd, H., ed. (1995) Advanced Computer-Assisted Techniques in Drug Discovery, VCH
7. Kubinyi, H. (1995) in Burger's Medicinal Chemistry (Vol. 1, 5th edn) (Wolff, M.E., ed.), pp. 497-571, John Wiley & Sons
8. th European Symposium on Quantitative Structure-Activity Relationships, Barcelona, 1994), Prous Science
9. Pliska, V., Testa, B. and van de Waterbeemd, H., eds (1996) Lipophilicity in Drug Action and Toxicology, VCH
10. van de Waterbeemd, H., ed. (1996) Structure-Property Correlations in Drug Research, Academic Press
11. van de Waterbeemd, H. (1996) in The Practice of Medicinal Chemistry (Wermuth, C.G., ed.), pp. 367-389, Academic Press
12. Böhm. H-J., Klebe, G. and Kubinyi, H. (1996) Wirkstoffdesign, pp. 363-380 and 399-436, Spektrum Akademischer Verlag
13. th European Symposium on Quantitative Structure-Activity Relationships, Lausanne, 1996), Verlag Helvetica Chimica Acta and VCH
14. Free, S.M., Jr and Wilson, J.W. (1964) J. Med. Chem. 7, 395-399
15. Hansch, C. and Fujita, T. (1964) J. Am. Chem. Soc. 86, 1616-1626
16. Kubinyi, H (1997) Drug Discovery Today 2, part 2
17. Cramer. R.D., III, Patterson, D.E. and Bunce, J.D. (1988) J. Am. Chem. Soc. 110, 5959-5967
18. Kubinyi, H., ed. (1993) 3D QSAR in Drug Design. Theory, Methods and Applications, ESCOM Science Publishers
19. Green, S.M. and Marshall, G.R. (1995) Trends Pharmacol. Sci. 16, 285-291
20. Kim, K.H. (1995) in Molecular Similarity in Drug Design (Dean, P.M., ed.), pp. 291-331, Chapman & Hall
21. Martin, Y.C. and Lin, C.T. (1996) in The Practice of Medicinal Chemistry (Wermuth, C.G., ed.), pp. 459-483, Academic Press
22. Blankley, C.J. (1996) in Structure-Property Correlations in Drug Research (van de Waterbeemd, H., ed.), pp. 111-177, Academic Press
23. Martin, Y.C., Kim, K-H. and Lin, C.T. (1996) in Advances in Quantitative Structure Property Relationships (Vol. I) (Charton, M., ed.), pp. 1-52, JAI Press
24. Kubinyi, H., Folkers, G. and Martin, Y.C., eds (1997) 3D QSAR in Drug Design. Ligand-Protein Interactions and Molecular Similarity (Vol. 2) and Recent Advances (Vol. 3), Kluwer Academic Publishers
25. Kubinyi, H., Folkers, G. and Martin, Y.C., eds (1997) 3D QSAR in Drug Design. Ligand-Protein Interactions and Molecular Similarity (Vol. 2) and Recent Advances (Vol. 3), Kluwer Academic Publishers
26. Böhm, H-J. (1994) J. Comput.-Aided Mol. Design 8, 243-256
27. Böhm, H-J. and Klebe, G. (1996) Angew. Chem. 108, 2750-2778, Angew. Chem., Int. Ed. Engl. 35, 2588-2614
28. Böhm, H-J. and Klebe, G. (1996) Angew. Chem. 108, 2750-2778, Angew. Chem., Int. Ed. Engl. 35, 2588-2614
29. Cramer, R.D., III and Milne, M. (1979) Am. Chem. Soc. Meeting, April 1979, Computer Chemistry Section. Abstr. no. 44
30. SYBYL/QSAR, Molecular Modelling Software, Tripos Inc., 1699 S. Hanley Road, St Louis, MO 63944, USA
31. Pearlman, R.S. (1993) Chem. Design Automation News 8 (8), 3-15
32. Sadowski, J. and Gasteiger, J. (1993) Chem. Rev. 93, 2567-2581
33. Bolin, J.T. et al. (1982) J. Biol. Chem. 257, 13650-13662
34. Bystroff, C., Oatley, S.J. and Kraut, J. (1990) Biochemistry 29, 3263-3277
35. Kearsley, S.K. and Smith, G.M. (1990) Tetrahedron Comput. Methodol. 3, 615-633
36. Klebe, G., Mietzner, T. and Weber, F. (1994) J. Comput.-Aided Mol. Design 8, 751-778
37. Cho, S.J. and Tropsha, A. (1995) J. Med. Chem. 38, 1060-1066
38. Kroemer, R.T. and Hecht, P. (1995) J. Comput.-Aided Mol. Design 9, 396-406
39. Norinder, U. (1996) J. Chemomet. 10, 95-105
40. th European Symposium on Quantitative Structure-Activity Relationships, Lausanne, 1996) (van de Waterbeemd, H., Testa, B. and Folkers, G., eds), pp. 379-395, Verlag Helvetica Chimica Acta and VCH
41. Klebe, G., Abraham, U. and Mietzner, T. (1994) J. Med. Chem. 37, 4130-4146
42. Kubinyi, H. (1994) Chemie in unserer Zeit 23, 281-290
43. Rum, G. and Herndon, W.C. (1991) J. Am. Chem. Soc. 113, 9055-9060
44. Good, A.C., Peterson, S.J. and Richards, W.G. (1993) J. Med. Chem. 36, 2929-2937
45. Good, A.C. ( 1995) in Molecular Similarity in Drug Design (Dean, P.M., ed.), pp. 24-56, Chapman & Hall
46. th European Symposium on Quantitative Structure-Activity Relationships, Lausanne, 1996) (van de Waterbeemd, H., Testa, B. and Folkers, G., eds), pp. 7-28, Verlag Helvetica Chimica Acta and VCH
47. Martin, Y.C. et al. (1995) J. Med. Chem. 38, 3009-3015